Follow
Gail Matthews
Gail Matthews
Verified email at kirby.unsw.edu.au
Title
Cited by
Cited by
Year
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
C Phetsouphanh, DR Darley, DB Wilson, A Howe, C Munier, SK Patel, ...
Nature immunology 23 (2), 210-216, 2022
6362022
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
GL Dean, SG Edwards, NJ Ives, G Matthews, EF Fox, L Navaratne, ...
Aids 16 (1), 75-83, 2002
5412002
Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men
T van de Laar, O Pybus, S Bruisten, D Brown, M Nelson, S Bhagani, ...
Gastroenterology 136 (5), 1609-1617, 2009
4262009
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
4222021
A global scientific strategy to cure hepatitis B
PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ...
The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019
4172019
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label …
JK Rockstroh, M Nelson, C Katlama, J Lalezari, J Mallolas, M Bloch, ...
The lancet HIV 2 (8), e319-e327, 2015
4072015
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
TJ Van De Laar, GV Matthews, M Prins, M Danta
Aids 24 (12), 1799-1812, 2010
3562010
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3162021
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ...
The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018
2992018
Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy
GV Matthews, M Bower, S Mandalia, T Powles, MR Nelson, BG Gazzard
Blood, The Journal of the American Society of Hematology 96 (8), 2730-2734, 2000
2572000
Potential role for Interleukin‐28B genotype in treatment decision‐making in recent hepatitis C virus infection
J Grebely, K Petoumenos, M Hellard, GV Matthews, V Suppiah, ...
Hepatology 52 (4), 1216-1224, 2010
2472010
An open-label study of tenofovir in HIV-1 and hepatitis B virus co-infected individuals
M Nelson, S Portsmouth, J Stebbing, M Atkins, A Barr, G Matthews, ...
Aids 17 (1), F7-F10, 2003
2332003
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
GV Matthews, A Bartholomeusz, S Locarnini, A Ayres, J Sasaduesz, ...
Aids 20 (6), 863-870, 2006
2292006
Sexually transmitted hepatitis C infection: the new epidemic in MSM?
D Bradshaw, G Matthews, M Danta
Current opinion in infectious diseases 26 (1), 66-72, 2013
1832013
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection
GJ Dore, M Hellard, GV Matthews, J Grebely, PS Haber, K Petoumenos, ...
Gastroenterology 138 (1), 123-135. e2, 2010
1782010
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand
GV Matthews, A Avihingsanon, SR Lewin, J Amin, R Rerknimitr, ...
Hepatology 48 (4), 1062-1069, 2008
1622008
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study
GV Matthews, CA Sabin, S Mandalia, F Lampe, AN Phillips, MR Nelson, ...
Aids 16 (1), 53-61, 2002
1622002
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection
J Grebely, ST Pham, GV Matthews, K Petoumenos, RA Bull, B Yeung, ...
Hepatology 55 (4), 1058-1069, 2012
1422012
IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study
V Suppiah, S Gaudieri, NJ Armstrong, KS O'Connor, T Berg, M Weltman, ...
PLoS medicine 8 (9), e1001092, 2011
1332011
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C
GV Matthews, M Hellard, P Haber, B Yeung, P Marks, D Baker, ...
Clinical infectious diseases 48 (5), 650-658, 2009
1302009
The system can't perform the operation now. Try again later.
Articles 1–20